Pharmacokinetic Study of Marine Active in Health Men
Unknown status
China Medical University Hospital
Phase 1
1969-12-31
Hyperuricemia is often associated with metabolic syndrome, which is a known precursor of
atherosclerosis. The Yaizu Suisankagaku Industry Company have developed industrial
production, named Marine Active. Human clinical trials showed reduction of creatine
phosphokinase activity and sero-uric acid. Randomize, double blind clinical trial is entrust
to our hospital. This study design is blood sampling from the health men who take 1 gm of
marine active to analyse the pharmacokinetics of anserine.
A Clinical Double Blind, Randomized Study of the Efficacy of Hyperuricemia Treatment With Anserine Product.
Unknown status
China Medical University Hospital
Phase 2
2004-07-01
Hyperuricemia is a common metabolic disorder.The Yaizu Suisankagaku Industry Company have
developed industrial production named Marine Active, was able to offer anti-fatigue activity
by animal trial data. Human clinical trials showed reduced creatine phosphokinase activity
and a sero-uric acid reduction activity was also observed. So we are committed to design the
clinical randomized, double blind study about hyperuricemia management with Marine Active.
All these efforts are hoped to find a novel method to manage hyperuricemia.
Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
Completed
Fundação de Amparo à Pesquisa do Estado de São Paulo
Phase 4
2014-08-01
The purpose of this study is to assess whether the switch from branded to generic warfarin or
between different generic warfarin tablets may cause fluctuation in the results of
coagulation tests (International Normalized Rate, acronym INR) in patients, thus predisposing
them to unnecessary risks.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
